HRYZ-T101 / HRYZ BIOTECH - LARVOL DELTA

HRYZ-T101 Injection for HPV18 Positive Solid Tumor (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: HRYZ Biotech Co. | Not yet recruiting ➔ Recruiting

Enrollment open • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Head and Neck Cancer • Oncology • Penile Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Vaginal Cancer • Vulvar Cancer • HLA-DRB1

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor (clinicaltrials.gov) - P1 | N=17 | Recruiting | Sponsor: HRYZ Biotech Co. | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Head and Neck Cancer • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Vaginal Cancer • Vulvar Cancer • HLA-DRB1

HRYZ-T101 Injection for HPV18 Positive Solid Tumor (clinicaltrials.gov) - P1 | N=32 | Not yet recruiting | Sponsor: SYZ Cell Therapy Co..

New P1 trial • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Head and Neck Cancer • Oncology • Penile Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Vaginal Cancer • Vulvar Cancer • HLA-DRB1

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor (clinicaltrials.gov) - P1 | N=17 | Not yet recruiting | Sponsor: SYZ Cell Therapy Co..

Metastases • New P1 trial • Anal Carcinoma • Cervical Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Head and Neck Cancer • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Vaginal Cancer • Vulvar Cancer • HLA-DRB1